Trial Results

Results of clinical trials are presented at scientific conferences and/or published in peer-reviewed papers. The list below refers to summaries of trial results compiled by the CIHR Canadian HIV Trials Network.

CTN studies that have published results:

CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption

CTN 237: Influenza vaccination strategies using Fluviral in HIV-positive adults [NEW]

CTN 229: Effect of AGS-004 immunotherapeutic agent in HIV-positive people on HAART

CTN 227: Hepatitis C therapeutic vaccine

CTN 221: NGX-4010 for the treatment of painful HIV-associated neuropathy

CTN 205: Valproic acid and HIV

CTN 203: Phase I/II study of Remune® plus Amplivax™

CTN 190: Strategies for management of ART (SMART)

CTN 173: Vaccination before treatment interruption

CTN 167: Options with antiretrovirals (OPTIMA)

CTN 145: rIL-2 to slow progression of HIV (SILCAAT)

CTN 110: Subcutaneous interleukin-2 in the setting of HIV infection